Press "Enter" to skip to content

FDA adviser resigns over approval of new Alzheimer’s drug

A member of a US Food and Drug Administration advisory committee said Wednesday he had resigned over the agency’s approval of a new Alzheimer’s drug.

A member of a US Food and Drug Administration advisory committee said Wednesday he had resigned over the agency’s approval of a new Alzheimer’s drug.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *